![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1136, 2007-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adverse events increase cost of CML treatment
Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adverse events increase cost of CML treatment
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 521, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Preventable adverse events cost UK NHS dearly
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 303, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adverse events cost US Medicare, hospitals dearly
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adverse events: significant cost impact in renal transplant
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 562, 2008-01 ,pp. :